Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

标题
Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients
作者
关键词
Immune-related adverse events, Nivolumab, Pembrolizumab, Advanced cancer, Response predictive factor
出版物
EUROPEAN JOURNAL OF CANCER
Volume 109, Issue -, Pages 21-27
出版商
Elsevier BV
发表日期
2019-01-24
DOI
10.1016/j.ejca.2018.10.014

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started